Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Dec 2004

Wainberg Sara, Husted Janice

Abstract excerpt

OBJECTIVE: Women who are carriers of BRCA gene mutations have an elevated lifetime risk of developing breast or ovarian cancer. Although a number of risk-reducing options are currently available to mutation carriers, uncertainty exists in terms of their efficacy. A systematic review of the literature was conducted to describe the utilization of screening and preventive surgery among unaffected mutation carriers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Decision Making

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Patient Compliance

Source

Identifiers

PMID: 15598752

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation.PMID 15598752Read ↗

Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.Semantic proximity Read ↗

Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers.Semantic proximity Read ↗

Decision aids for female BRCA mutation carriers: a scoping review.Semantic proximity Read ↗

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Semantic proximity Read ↗

Management options after prophylactic surgeries in women with BRCA mutations: a review.Semantic proximity Read ↗

Risk management options elected by women after testing positive for a BRCA mutation.Semantic proximity Read ↗

Uptake of breast cancer risk-management strategies among unaffected BRCA 1/2 carriers: a systematic review of international evidence.Semantic proximity Read ↗

Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.Semantic proximity Read ↗

Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers.Semantic proximity Read ↗

Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.Semantic proximity Read ↗

Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.Semantic proximity Read ↗

Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.